𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment and Outcome of 82 Patients with Angiosarcoma

✍ Scribed by John A. Abraham; Francis J. Hornicek; Adam M. Kaufman; David C. Harmon; Dempsey S. Springfield; Kevin A. Raskin; Henry J. Mankin; David G. Kirsch; Andrew E. Rosenberg; G. Petur Nielsen; Vikram Desphpande; Herman D. Suit; Thomas F. DeLaney; Sam S. Yoon

Book ID
111771961
Publisher
Springer
Year
2007
Tongue
English
Weight
282 KB
Volume
14
Category
Article
ISSN
1068-9265

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Neoadjuvant chemotherapy–specific and ov
Neoadjuvant chemotherapy–specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement
✍ Sheri L. DeMartelaere; Dianna Roberts; Michael A. Burgess; William H. Morrison; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 353 KB

## Abstract ## Background Recent isolated case reports have suggested a potential role for neoadjuvant chemotherapy in patients with angiosarcoma. The goal of this report was to investigate the overall treatment outcomes and the neoadjuvant chemotherapy–specific outcomes in patients with cutaneous

Outcomes after definitive treatment for
Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp
✍ B. Ashleigh Guadagnolo; Gunar K. Zagars; Dejka Araujo; Vinod Ravi; Thomas D. She πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 206 KB

## Abstract ## Background The aim of the present analysis was to retrospectively evaluate outcomes in patients with cutaneous angiosarcoma of the face/scalp treated curatively with surgery, radiation therapy (RT), or a combination of surgery and RT. ## Methods In all, 70 patients with nonmetasta

Paclitaxel in the treatment of patients
Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face
✍ Farid Fata; Eileen O'Reilly; David Ilson; David Pfister; David Leffel; David P. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 54 KB πŸ‘ 1 views

## BACKGROUND. Angiosarcomas are rare tumors. Based on a complete response observed in a patient with angiosarcoma of the scalp treated with paclitaxel in a Phase II trial, the authors treated a cohort of patients with angiosarcoma of the scalp or face with paclitaxel as single agent. ## METHODS.